BNP PARIBAS FINANCIAL MARKETS - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$11,682,000
+187.9%
4,425
+28.7%
0.00%
Q4 2019$4,058,000
+0.6%
3,439
+46.7%
0.00%
Q3 2019$4,032,000
-63.0%
2,344
+1.8%
0.00%
Q2 2019$10,911,000
-47.6%
2,302
-28.6%
0.00%
Q1 2019$20,827,000
+22786.8%
3,224
+17811.1%
0.00%
Q4 2018$91,000180.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$46,175,00019.63%
Endurant Capital Management LP 465,650$2,207,0000.87%
HARVARD MANAGEMENT CO INC 505,871$2,398,0000.59%
Partner Investment Management, L.P. 103,596$491,0000.52%
MEITAV INVESTMENT HOUSE LTD 639,465$3,002,0000.20%
Hillhouse Capital Management 399,308$1,893,0000.06%
ArrowMark Colorado Holdings LLC 703,375$3,334,0000.03%
PFM Health Sciences, LP 121,848$578,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 159,200$755,0000.01%
OXFORD ASSET MANAGEMENT LLP 77,024$365,0000.01%
View complete list of NEON THERAPEUTICS INC shareholders